ESR1 and breast carcinoma: In multivariable multinomial models including all tumor characteristics that were significantly different between non‐BRCA and BRCA1‐positive breast cancer patients, only ER‐negativity remained significant (ORBRCA1 vs non‐BRCA: 5.19 [2.68–10.06]) (Table 1).